← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-11 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
CGTBiologicstaleInnovative Cellular Therapeutic…Preclinical

gucy2c cart cells (gucy2c cart cells)

Malignant Neoplasms of Digestive Organs · Malignant Neoplasms of Digestive Organs

#MalignantNeoplasmsofDigestiveOrg#CGT#Preclinical#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodyBiologicstaleGilead SciencesPhase 2

the doxorubicin conjugate of milatuzumab (hLL1-DOX, hLL1-DOX (the doxorubicin conjugate of milatuzumab))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodyBiologicstaleSuZhou Stainwei Biotech Inc.Phase 1

hPV19 mAb (hPV19 mAb)

Solid Tumors · Solid Tumors

#SolidTumors#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai iCELL Biotechnology Co…Phase 1

haploid allogeneic NK cell therapy (haploid allogeneic NK cell therapy)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleHawaii Pacific HealthPhase 2

ranibizumab (Lucentis, high-dose ranibizumab)

PCV; Polypoidal Choroidal Vasculopathy · PCV

#PCV#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
CGTBiologicstaleUniversity of PennsylvaniaPhase 1

huCART19 Cells (huCART19 Cells)

Chemotherapy Resistant Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBlueWhale Bio (Cohort D only)Phase 1

huCART19-IL18 (huCART19-IL18)

Chronic Lymphocytic Leukemia; Non-hodgkin Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of PennsylvaniaPhase 1

huCART19-IL18-eDHFR cells (huCART19-IL18-eDHFR cells)

Relapsed or Refractory Follicular Lymphoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleMinerva Biotechnologies Corpora…Phase 1

huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells (huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleMinerva Biotechnologies Corpora…Phase 1

huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells @ RP2D (huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells @ RP2D)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleZhujiang HospitalPhase 1

humanized CD19 CAR-T Cells with TLR2 (humanized CD19 CAR-T Cells with TLR2)

B Lymphoblastic Leukemia/Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells (i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells)

Relapsed Neuroblastoma; Refractory Neuroblastoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleUNC Lineberger Comprehensive Ca…Phase 1

iC9-CAR.B7-H3 T Cell Therapy (iC9-CAR.B7-H3 T Cell Therapy)

Breast Cancer; Relapse · B7-H3

#B7-H3#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleUNC Lineberger Comprehensive Ca…Phase 1

iC9-CAR.B7-H3 T cell infusion (iC9-CAR.B7-H3 T cell infusion)

Pancreas Cancer; Relapse · B7-H3

#B7-H3#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleUNC Lineberger Comprehensive Ca…Phase 1

iC9-CAR.B7-H3 T cells (iC9-CAR.B7-H3 T cells)

Ovary Neoplasm; Ovarian Cancer · B7-H3

#B7-H3#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleThe V FoundationPhase 1

iC9-CAR19 T cells (iC9-CAR19 T cells)

Lymphoma; Lymphoma, B-Cell · Lymphoma

#Lymphoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBellicum PharmaceuticalsPhase 1

iC9.GD2.CAR.IL-15 T Infusion (iC9.GD2.CAR.IL-15 T Infusion)

Lung Cancer; Small Cell Lung Carcinoma · GD2

#GD2#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleUNC Lineberger Comprehensive Ca…Phase 1

iC9.GD2.CAR.IL-15 T-cells (iC9.GD2.CAR.IL-15 T-cells)

Neuroblastoma; Osteosarcoma · GD2

#GD2#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleGuangzhou Ruixin Biotechnologic…Phase 1

iNK cells (iNK cells)

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 58.7%임상시험 1상태 RECRUITING
CGTBiologicstaleZhejiang UniversityPhase 1

iPSC-NK cells (iPSC-NK cells)

AML, Adult · AML, Adult

#AMLAdult#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING

170 / 177 페이지

← 이전다음 →